Athira Pharma, Inc (ATHA) insider trading
Every open-market stock purchase and sale by Athira Pharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $43.2K over the last 12 months (5 sales). No open-market buys.
- Last insider buy: Kelly A Romano (Insider), $66.2K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $43.2K (5 sales). Last close $6.75 on Jan 9, 2026.
Recent ATHA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | Mark James Litton (CEO) | Sold | $17.8K |
| Jan 2, 2026 | Martin Javier San (C-suite exec) | Sold | $11.3K |
| Jan 2, 2026 | Kevin Church (C-suite exec) | Sold | $6K |
| Jan 2, 2026 | Mark Worthington (C-suite exec) | Sold | $6K |
| Jan 2, 2026 | Robert Renninger (CFO) | Sold | $2K |
| Dec 31, 2025 | Mark Worthington (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Kevin Church (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Martin Javier San (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Robert Renninger (CFO) | Bought (not open market) | — |
| Dec 31, 2025 | Mark James Litton (CEO) | Bought (not open market) | — |
| Dec 24, 2025 | Mark James Litton (CEO) | Bought (not open market) | — |
| Dec 24, 2025 | Robert Renninger (CFO) | Bought (not open market) | — |
| Dec 24, 2025 | Martin Javier San (C-suite exec) | Bought (not open market) | — |
| Dec 24, 2025 | Mark Worthington (C-suite exec) | Bought (not open market) | — |
| Dec 24, 2025 | Kevin Church (C-suite exec) | Bought (not open market) | — |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $24.4M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $22.5M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $8.7M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $8.1M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $7.5M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $6.3M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $2.9M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $2.1M |
| Dec 23, 2025 | Perceptive Advisors LLC (10% owner) | Bought (not open market) | $5.5K |
| Nov 18, 2025 | Robert Renninger (CFO) | Bought (not open market) | $2.3K |
Who's trading ATHA
- Kevin Church, C-suite exec: sold $6K (1 sale), last Jan 2, 2026
- Mark James Litton, CEO: sold $17.8K (1 sale), last Jan 2, 2026
- Robert Renninger, VP: sold $2K (1 sale), last Jan 2, 2026
- Martin Javier San, C-suite exec: sold $11.3K (1 sale), last Jan 2, 2026
- Mark Worthington, C-suite exec: sold $6K (1 sale), last Jan 2, 2026
- Perceptive Advisors LLC, 10% owner: other filings, last Dec 23, 2025
Get free alerts when an insider at Athira Pharma, Inc files a new trade →